Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Solid Tumor Testing Market in the US
Solid tumor testing or screening is done for the early detection of cancer, enabling effective treatment measures to avoid the spread of cancerous cells throughout the body. The testing procedure involves testing of samples such as urine, blood, and other bodily substances. Further, cancer testing also involves conducting genetic tests to analyze certain gene mutations that are linked to certain cancer types. Biopsy, colonoscopy, Papanicolaou (Pap) test, and fecal occult blood tests are some of the tests that are performed for cancer screening.
Technavio’s analysts forecast the solid tumor testing market in the US to grow at a CAGR of 11.1% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the solid tumor testing market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of solid tumor testing products, such as assays or kits and bench-top instruments.
The market is divided into the following segments based on cancer types:
• Breast cancer
• Lung cancer
• Colorectal cancer
• Prostate cancer
• Cervical cancer
• Other (including pancreatic cysts and thyroid nodules)
Technavio's report, Solid Tumor Testing Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Molecular
• Agilent Technologies (Dako)
• Beckman Coulter
• Roche Diagnostics
Other prominent vendors
• 20/20 GeneSystems
• Adaptive Biotechnologies
• Advanced Cell Diagnostics
• Affymetrix
• Agena Bioscience
• Ambry Genetics
• ApoCell
• Avant Diagnostics
• Biological Dynamics
• Boditech Med
• Becton, Dickinson and Company (BD)
• Biocare Medical
• Bio-Rad Laboratories
• Castle Biosciences
• CDx Diagnostics
• Celerus Diagnostics
• Cancer Genetics
• Caris Life Sciences
• Clarient Diagnostic Services
• DiaTech Oncology
• Enzo Biochem
• Epic Sciences
• EDP Biotech
• Eutropics Pharmaceuticals
• Fujirebio Diagnostics
• Genalyte
• Hologic
• Janssen Diagnostics
• Myriad Genetics
• Omnyx
• OxfordGene Technology
• Oncospire Genomics
• OncoCyte
• OvaGene Oncology
• Pathway Genomics
• Quest Diagnostics
• QIAGEN
• RiboMed Biotechnologies
• Sequenom
• Siemens Healthcare Diagnostics
• Thermo Fisher Scientific
• Tosoh Bioscience
• TrimGen
Market driver
• High demand for personalized medicines
• For a full, detailed list, view our report
Market challenge
• Regulatory issues
• For a full, detailed list, view our report
Market trend
• Ready-to-use reagents
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Solid tumor testing or screening is done for the early detection of cancer, enabling effective treatment measures to avoid the spread of cancerous cells throughout the body. The testing procedure involves testing of samples such as urine, blood, and other bodily substances. Further, cancer testing also involves conducting genetic tests to analyze certain gene mutations that are linked to certain cancer types. Biopsy, colonoscopy, Papanicolaou (Pap) test, and fecal occult blood tests are some of the tests that are performed for cancer screening.
Technavio’s analysts forecast the solid tumor testing market in the US to grow at a CAGR of 11.1% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the solid tumor testing market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of solid tumor testing products, such as assays or kits and bench-top instruments.
The market is divided into the following segments based on cancer types:
• Breast cancer
• Lung cancer
• Colorectal cancer
• Prostate cancer
• Cervical cancer
• Other (including pancreatic cysts and thyroid nodules)
Technavio's report, Solid Tumor Testing Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Molecular
• Agilent Technologies (Dako)
• Beckman Coulter
• Roche Diagnostics
Other prominent vendors
• 20/20 GeneSystems
• Adaptive Biotechnologies
• Advanced Cell Diagnostics
• Affymetrix
• Agena Bioscience
• Ambry Genetics
• ApoCell
• Avant Diagnostics
• Biological Dynamics
• Boditech Med
• Becton, Dickinson and Company (BD)
• Biocare Medical
• Bio-Rad Laboratories
• Castle Biosciences
• CDx Diagnostics
• Celerus Diagnostics
• Cancer Genetics
• Caris Life Sciences
• Clarient Diagnostic Services
• DiaTech Oncology
• Enzo Biochem
• Epic Sciences
• EDP Biotech
• Eutropics Pharmaceuticals
• Fujirebio Diagnostics
• Genalyte
• Hologic
• Janssen Diagnostics
• Myriad Genetics
• Omnyx
• OxfordGene Technology
• Oncospire Genomics
• OncoCyte
• OvaGene Oncology
• Pathway Genomics
• Quest Diagnostics
• QIAGEN
• RiboMed Biotechnologies
• Sequenom
• Siemens Healthcare Diagnostics
• Thermo Fisher Scientific
• Tosoh Bioscience
• TrimGen
Market driver
• High demand for personalized medicines
• For a full, detailed list, view our report
Market challenge
• Regulatory issues
• For a full, detailed list, view our report
Market trend
• Ready-to-use reagents
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
